News

Patents for Human Genes, Diagnostic Tests Generate Policy Debate

Isolated human genes would be patentable, and the costs of medical diagnostic tests would jump under a recently introduced bill to revamp patent eligibility, panelists at an American Civil Liberties Union virtual briefing said Monday—a stance that former patent officials labeled “scaremongering.”

Read More »

New high-level lobby group will promote role of IP in US innovation

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating how much it pays for certain medications, and penalizing drug makers that hike prices faster than inflation. With new responsibility comes new bureaucracy, new documents obtained by STAT show.

Read More »

The IP News that Mattered Most in 2022, According to You

WTO divided over expanding COVID-19 IP waiver

C4IP Presents Webinar on COVID Waiver Extension

Two former Commerce Department executives take on intellectual property protection

Ex-IP Chiefs Urge US To Focus On Next Pandemic, Not Waiver

Former Commerce, USPTO Heads Push for U.S. to Lead Opposition to Extending WTO’s COVID IP Waiver

Is China set to pass the US as the world’s lead innovators?

How China steals U.S. intellectual property

Iancu-Backed Group Urges Lawmakers To Support Tillis IP Bill

Letters Seek to Dispel Gene Patent ‘Scaremongering’ Surrounding Tillis’ Patent Eligibility Bill

“Any suggestion that this legislation would allow companies to patent anyone’s DNA is simply false,” C4IP writes, adding that the ‘scaremongering’…ignores the ...

Patents for Human Genes, Diagnostic Tests Generate Policy Debate

Isolated human genes would be patentable, and the costs of medical diagnostic tests would jump under a recently introduced bill to revamp ...

New high-level lobby group will promote role of IP in US innovation

Medicare has a herculean task ahead of setting up an infrastructure to take on an entirely new function for the program — regulating ...
Scroll to Top